Insulin Expression Inducer, BRD7389

Ref. 3D-BQA38211

Produktinformation

• Name: Insulin Expression Inducer, BRD7389
• Marke: Biosynth
• Beschreibung: BRD7389 is a novel anthracene derivative that induces insulin expression in the pancreas. BRD7389 is highly selective for the pancreatic beta-cells, and it can be used as a potential therapeutic agent for diabetes mellitus type 2.; BRD7390 was shown to induce insulin expression in human pancreatic beta cells with high potency and selectivity.

Chemische Eigenschaften

• Molekulargewicht: 366.41 g/mol
• Formel: C₂₄H₁₈N₂O₂
• Reinheit: Min. 95%